Indian F&O data, and the evidence about what not to trade · educational
📡 Radar📜 Earnings🌦️ Weather🌡️ Volatility🏭 Sectors🧭 Crowd📈 Extremes🔬 Myths🛡 Scorecard

SYNGENE · Healthcare

Price
₹387.6
1M / 3M / 1Y
-3.7% / -13.5% / -41.8%
20d realized vol
22%
Traded value (60d med)
₹31 cr
Delivery % (20d avg)
57%
Days in F&O ban since 2020
0

📜 Results-day history

Typical move 1.8% · up on the day 31% of 26 events · moved 4%+ in 27% · worst -6.0% / best +5.9%

Reaction dayMoveOpen gapNext 5dAnnounced
2026-07-23-0.8%-0.3%-1.0%after close
2026-04-20-0.0%+0.8%+0.3%after close
2026-01-19-0.3%-0.8%-13.1%during mkt
2025-10-30-1.3%-0.3%-4.6%after close
2025-07-21+2.1%+0.1%+2.9%after close
2025-04-22+1.5%+0.4%-14.5%during mkt
2025-01-24-6.0%-0.1%-6.2%after close
2024-10-24+5.1%-0.2%-2.2%after close
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.
1KSG Terminal · data from NSE public archives · regenerated nightly